RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 41.3811

Change

+1.45 (+3.62)%

Market Cap

N/A

Volume

8.56K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+0.47 (+5.40%)

USD 8.14B
QLD ProShares Ultra QQQ

+3.77 (+5.11%)

USD 5.50B
SSO ProShares Ultra S&P500

+3.46 (+5.06%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

+4.06 (+7.50%)

USD 2.91B
TECL Direxion Daily Technology Bull..

+2.78 (+6.96%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

+2.71 (+9.51%)

USD 1.19B
USD ProShares Ultra Semiconductors

+1.25 (+4.09%)

USD 0.61B
UDOW ProShares UltraPro Dow30

+5.04 (+7.98%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

+3.98 (+8.63%)

USD 0.53B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+1.01 (+0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.89 (+0%)

USD 9.26B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.10 (0%)

USD 0.21B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.41 (+0%)

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.93% 67% D+ 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.93% 67% D+ 45% F
Trailing 12 Months  
Capital Gain -14.02% 45% F 23% F
Dividend Return 1.25% 77% C+ 25% F
Total Return -12.77% 43% F 21% F
Trailing 5 Years  
Capital Gain 47.24% 39% F 55% F
Dividend Return 4.49% 27% F 8% B-
Total Return 51.73% 36% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 8.36% 29% F 64% D
Dividend Return 8.74% 28% F 59% D-
Total Return 0.39% 23% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 29.03% 97% N/A 34% F
Risk Adjusted Return 30.12% 50% F 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.